Will The US Economic Rebound Falter In 2020’s Second Half?
Macro Briefing | 12 August 2020
Coronavirus: does the common cold protect you from COVID?
Moderna Spikes 11% On $1.5B US Supply Deal For Covid-19 Vaccine
Mexico to trial China and U.S. Covid-19 vaccines, may produce some
Exposing COVID-19's "Orgy Of Incoherence"
Texas Becomes Third State To Pass Half A Million Confirmed COVID-19 Cases: Live Updates
WTI 'Off The Lows' After Bigger Than Expected Crude Draw
Rapid Reviews: COVID-19 looks at neurological side effects of COVID-19, vaccines, and more
Dutch Government Adopts 'Mandatory Quarantine' For Everyone Exposed To COVID-19: Live Updates
Russia first to approve Covid-19 vaccine
NYC shoppers 4 times more likely to frequent stores adhering to social distance guidelines
Here’s why we won’t see a housing crisis after COVID-19
Mid-Market Update: S&P 500 eyes record on data and vaccine news, Oil rallies, Gold and dollar sink
Chart of the week – Recovering with a ‘v’ for COVID or a ‘u’ for ultimately?
US retailers are counting on Chinese consumers this earnings season
Scepticism as Russia claims coronavirus vaccine breakthrough with Sputnik V
Vaxart's (VXRT) Stock Will Surge 130% From Current Levels, Says Analyst
Inovio To Start Phase 2/3 Study Of Covid-19 Candidate In Sept.; Shares Drop 8%
S&P Futures Hit All Time Highs On Stimulus, Vaccine Hopes; Gold, Silver Tumble
New Zealand Revives Lockdown 2 Months After 'Declaring Victory' Over Coronavirus: Live Updates
Novavax Rises 5% On Earnings; $2B Covid-19 Vaccine Funding
Ligand scoops up Pfenex for up to $516M, adding proteins to their antibody chickens and delivery tech
China Continues To Lead World Equity Markets In 2020
Many UK healthcare workers may have had coronavirus without knowing it – new survey of smell loss
Tencent Music Tops Revenue Estimates As Paid User Base Grows By 52%
How Does Moderna Stack Up in the COVID-19 Vaccine Pricing Wars? Analyst Weighs In
US small caps set for ‘several years of dominance’
Certara adds to its COVID-19 toolkit with virtual trials module
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies